Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting leukemia stem cells.

Literature DB >> 20212485

Targeting leukemia stem cells.

Hanna K A Mikkola, Caius G Radu, Owen N Witte.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2010 PMID： 20212485 DOI： 10.1038/nbt0310-237

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

10 in total

Review 1. Acute myeloid leukemia stem cells.

Authors: John E Dick
Journal: Ann N Y Acad Sci Date: 2005-06 Impact factor: 5.691

2. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.

Authors: E H Estey; P F Thall; S Pierce; J Cortes; M Beran; H Kantarjian; M J Keating; M Andreeff; E Freireich
Journal: Blood Date: 1999-04-15 Impact factor: 22.113

3. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.

Authors: Yoriko Saito; Naoyuki Uchida; Satoshi Tanaka; Nahoko Suzuki; Mariko Tomizawa-Murasawa; Akiko Sone; Yuho Najima; Shinsuke Takagi; Yuki Aoki; Atsushi Wake; Shuichi Taniguchi; Leonard D Shultz; Fumihiko Ishikawa
Journal: Nat Biotechnol Date: 2010-02-14 Impact factor: 54.908

4. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

Authors: Fumihiko Ishikawa; Shuro Yoshida; Yoriko Saito; Atsushi Hijikata; Hiroshi Kitamura; Satoshi Tanaka; Ryu Nakamura; Toru Tanaka; Hiroko Tomiyama; Noriyuki Saito; Mitsuhiro Fukata; Toshihiro Miyamoto; Bonnie Lyons; Koichi Ohshima; Naoyuki Uchida; Shuichi Taniguchi; Osamu Ohara; Koichi Akashi; Mine Harada; Leonard D Shultz
Journal: Nat Biotechnol Date: 2007-10-21 Impact factor: 54.908

5. IFNalpha activates dormant haematopoietic stem cells in vivo.

Authors: Marieke A G Essers; Sandra Offner; William E Blanco-Bose; Zoe Waibler; Ulrich Kalinke; Michel A Duchosal; Andreas Trumpp
Journal: Nature Date: 2009-02-11 Impact factor: 49.962

6. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Authors: Bob Löwenberg; Wim van Putten; Matthias Theobald; Jurg Gmür; Leo Verdonck; Pieter Sonneveld; Martin Fey; Harry Schouten; Georgine de Greef; Augustin Ferrant; Tibor Kovacsovics; Alois Gratwohl; Simon Daenen; Peter Huijgens; Marc Boogaerts
Journal: N Engl J Med Date: 2003-08-21 Impact factor: 91.245

Review 7. The leukemic stem cell niche: current concepts and therapeutic opportunities.

Authors: Steven W Lane; David T Scadden; D Gary Gilliland
Journal: Blood Date: 2009-04-28 Impact factor: 22.113

8. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells.

Authors: Andrea Viale; Francesca De Franco; Annette Orleth; Valeria Cambiaghi; Virginia Giuliani; Daniela Bossi; Chiara Ronchini; Simona Ronzoni; Ivan Muradore; Silvia Monestiroli; Alberto Gobbi; Myriam Alcalay; Saverio Minucci; Pier Giuseppe Pelicci
Journal: Nature Date: 2009-01-01 Impact factor: 49.962

9. Efficient tumour formation by single human melanoma cells.

Authors: Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal: Nature Date: 2008-12-04 Impact factor: 49.962

10. Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial.

Authors: Donald W Milligan; Keith Wheatley; Timothy Littlewood; Jenny I O Craig; Alan K Burnett
Journal: Blood Date: 2006-02-16 Impact factor: 22.113

10 in total

1. Implantable microenvironments to attract hematopoietic stem/cancer cells.

Authors: Jungwoo Lee; Matthew Li; Jack Milwid; Joshua Dunham; Claudio Vinegoni; Rostic Gorbatov; Yoshiko Iwamoto; Fangjing Wang; Keyue Shen; Kimberley Hatfield; Marianne Enger; Sahba Shafiee; Emmet McCormack; Benjamin L Ebert; Ralph Weissleder; Martin L Yarmush; Biju Parekkadan
Journal: Proc Natl Acad Sci U S A Date: 2012-11-12 Impact factor: 11.205

2. AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.

Authors: Shanshan Pei; Mohammad Minhajuddin; Biniam Adane; Nabilah Khan; Brett M Stevens; Stephen C Mack; Sisi Lai; Jeremy N Rich; Anagha Inguva; Kevin M Shannon; Hyunmin Kim; Aik-Choon Tan; Jason R Myers; John M Ashton; Tobias Neff; Daniel A Pollyea; Clayton A Smith; Craig T Jordan
Journal: Cell Stem Cell Date: 2018-06-14 Impact factor: 24.633

Targeting leukemia stem cells.

Review 1. Acute myeloid leukemia stem cells.

2. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.

3. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.

4. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

5. IFNalpha activates dormant haematopoietic stem cells in vivo.

6. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Review 7. The leukemic stem cell niche: current concepts and therapeutic opportunities.

8. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells.

9. Efficient tumour formation by single human melanoma cells.

10. Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial.

1. Implantable microenvironments to attract hematopoietic stem/cancer cells.

2. AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.

Review 3. Are cancer stem cells radioresistant?

4. Stemness of B-cell progenitors in multiple myeloma bone marrow.

5. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance.

6. Targeting myelogenous leukemia stem cells: role of the circulation.

7. Phenotypic heterogeneity of breast cancer stem cells.

8. Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia.

Review 9. Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities.

10. TIFAB accelerates MLL-AF9-Induced acute myeloid leukemia through upregulation of HOXA9.